With healthcare reform and the Centers for Medicare and Medicaid Services reducing reimbursement for preventable medical errors including certain types of hospital acquired infections, healthcare providers are challenged to adopt new approaches to reduce infections and their costs.

After more than four years of research and development, PMX is pleased to introduce EPA registered MicroGuard™antimicrobial copper alloys. The EPA has approved MicroGuard with public health claims that are based on extensive efficacy testing. MicroGuard touch surfaces are an ideal supplement to a multi-faceted approach to reduce hospital and community acquired infections. MicroGuard kills 99.9% of Gram-negative and Gram-positive bacteria* including MRSA within two hours when cleaned regularly.

While MicroGuard touch surfaces are not a substitute for good cleaning and disinfection practices, MicroGuard materials offer healthcare organizations an enormous competitive advantage. Unlike antimicrobial coatings or other additives, the antimicrobial efficacy of MicroGuard materials remains effective for the life of the product.

The EPA has approved MicroGuard antimicrobial copper materials and component hardware for more than 100 touch surface applications in healthcare facilities. With society increasingly concerned about coming in contact with bacteria and infections in healthcare environments, hospitals that add antibacterial touch surfaces to their infection prevention plan certainly demonstrate higher levels of quality care and patient safety.

MicroGuard touch surfaces are a visible difference that patients, visitors, and staff will appreciate. Available in a many attractive finishes and textures, MicroGuard materials can be used to replace stainless steel and other commonly used metals in healthcare environments.

To add MicroGuard materials and hardware to your infection prevention and control plan, contact us or call 800-531-5268.

*Testing demonstrates effective antibacterial activity against Staphylococcus aureus, Enterobacter aerogenes, Methicillin-Resistant Staphylococcus aureus (MRSA), Escherichia coli O157:H7, and Pseudomonas aeruginosa.